SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 221 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,798,000 | +7.9% | 46,749 | -17.4% | 0.12% | +5.1% |
| Q1 2018 | $2,593,000 | +13.3% | 56,606 | -1.4% | 0.12% | +17.0% |
| Q4 2017 | $2,288,000 | -1.5% | 57,404 | -1.1% | 0.10% | -6.5% |
| Q3 2017 | $2,323,000 | -7.3% | 58,066 | -0.2% | 0.11% | -9.3% |
| Q2 2017 | $2,507,000 | -1.1% | 58,167 | -28.2% | 0.12% | 0.0% |
| Q1 2017 | $2,536,000 | +14.0% | 81,031 | -8.0% | 0.12% | +12.4% |
| Q4 2016 | $2,224,000 | +1.0% | 88,078 | -1.1% | 0.10% | -0.9% |
| Q3 2016 | $2,202,000 | +3.7% | 89,024 | -14.6% | 0.11% | +12.8% |
| Q2 2016 | $2,124,000 | +59.5% | 104,257 | +19.4% | 0.09% | +56.7% |
| Q1 2016 | $1,332,000 | – | 87,345 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |